临床研究

基于限制性立方样条分析2型糖尿病患者系统免疫炎症指数与维生素D的关系

  • 赵敏 ,
  • 李智文 ,
  • 黄承龙 ,
  • 沈小菊 ,
  • 黄光明
展开
  • 广西医科大学第一附属医院药学部 (广西 南宁 530021 )

收稿日期: 2025-05-08

  网络出版日期: 2025-08-11

基金资助

广西医科大学第一附属医院临床研究攀登计划项目(YYZS2022009)

Relationship between systemic immune inflammation index and vitamin D in patients with type 2 diabetes based on restricted cubic spline

  • Min ZHAO ,
  • Zhiwen LI ,
  • Chenglong HUANG ,
  • Xiaoju SHEN ,
  • Guangming HUANG
Expand
  • Department of Pharmacy,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,Guangxi,ChinaCorrespongding author: HUANG Guangming E?mail: 513080380@qq. com

Received date: 2025-05-08

  Online published: 2025-08-11

摘要

目的 探究2型糖尿病患者血浆维生素D水平与系统免疫炎症指数(SII)的关联性。 方法 本研究为横断面研究,选取2018年1月至2023年6月期间在广西医科大学第一附属医院住院接受治疗的2型糖尿病患者作为研究对象,收集患者的一般人口学资料、既往病史、体格检测和实验室检查等数据。按照维生素D水平分成3组(缺乏组、不足组和充足组)。采用多元线性回归模型探索维生素D与SII的关联性。采用限制性立方样条模型分析维生素D与SII的非线性剂量反应关系。 结果 本研究共纳入5 716例2型糖尿病患者。SII在不同维生素D水平组有显著差异(P < 0.05),缺乏组SII最高。多元线性回归分析结果显示,调整性别、年龄、采血季节、体质量指数、高血压、血脂异常、慢性肾脏病等混杂因素后,维生素D水平与SII呈负相关(β = -2.68,95%CI:-3.56 ~ -1.81,P < 0.001),与缺乏组相比,充足组SII降低(β = -78.42,95%CI:-137.90 ~ -18.93,P = 0.01)。非线性立方样条模型表明维生素D水平和SII存在非线性剂量反应关系(P < 0.001)。 结论 2型糖尿病患者血浆维生素D水平与SII呈负相关。

本文引用格式

赵敏 , 李智文 , 黄承龙 , 沈小菊 , 黄光明 . 基于限制性立方样条分析2型糖尿病患者系统免疫炎症指数与维生素D的关系[J]. 实用医学杂志, 2025 , 41(15) : 2393 -2397 . DOI: 10.3969/j.issn.1006-5725.2025.15.015

Abstract

Objective To investigate the correlation between plasma vitamin D levels and a novel inflammatory marker, the systemic immune-inflammatory index (SII), in patients with type 2 diabetes. Methods This study adopted a cross-sectional design, in which patients diagnosed with type 2 diabetes who were admitted to the First Affiliated Hospital of Guangxi Medical University were enrolled as study participants. Data on demographic characteristics, medical history, physical examination findings, and laboratory test results were systematically collected. Participants were categorized into three groups based on their serum vitamin D levels: deficient, insufficient, and sufficient. The relationship between vitamin D levels and the SII was evaluated using a multivariate linear regression model. Additionally, a restricted cubic spline model was employed to assess the nonlinear dose-response association between vitamin D levels and SII. Results This study enrolled a total of 5,716 patients with type 2 diabetes. A statistically significant difference in the SII was observed across groups with varying vitamin D levels (P < 0.05), with the highest SII value found in the vitamin D-deficient group. Multivariate linear regression analysis revealed that, after adjusting for potential confounding factors including gender, age, season of blood collection, body mass index, hypertension, dyslipidemia, and chronic kidney disease, vitamin D levels were negatively associated with SII (β = -2.68, 95%CI: -3.56 to -1.81, P < 0.001). Compared with the vitamin D-deficient group, the vitamin D-sufficient group exhibited significantly lower SII levels (β = -78.42, 95%CI: -137.90 to -18.93, P = 0.01). Furthermore, the restricted cubic spline model indicated a nonlinear dose-response relationship between vitamin D levels and SII (P < 0.001). Conclusion There is a significant inverse correlation between plasma vitamin D levels and the SII in patients with type 2 diabetes.

参考文献

[1] 王丽敏, 陈志华, 张梅, 等. 中国老年人群慢性病患病状况和疾病负担研究[J]. 中华流行病学杂志, 2019, 40(3):277-283.
[2] KOTWAS A, KARAKIEWICZ B, ZABIELSKA P, et al. Epidemiological factors for type 2 diabetes mellitus: Evidence from the Global Burden of Disease[J]. Arch Public Health, 2021, 79(1):110-116. doi:10.1186/s13690-021-00632-1
[3] SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183:109-119. doi:10.1016/j.diabres.2023.110945
[4] ZMIJEWSKI M A. Vitamin D and Human Health[J]. Int J Mol Sci, 2019,20(1):145-150. doi:10.3390/ijms20010145
[5] HUANG H Y, LIN T W, HONG Z X, et al. Vitamin D and Diabetic Kidney Disease[J]. Int J Mol Sci, 2023, 24(4):3751-3768. doi:10.3390/ijms24043751
[6] 刘金霞,张才田.2型糖尿病患者血清25-羟维生素D3浓度与下肢血管病变的关系[J].实用医学杂志,2012,28(24):4082-4085.
[7] HU B, YANG X R, XU Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23):6212-6222. doi:10.1158/1078-0432.ccr-14-0442
[8] NIE Y, ZHOU H, WANG J, et al. Association between systemic immune-inflammation index and diabetes: A population-based study from the NHANES[J]. Front Endocrinol(Lausanne), 2023, 14:1245199. doi:10.3389/fendo.2023.1245199
[9] GUO W, SONG Y, SUN Y, et al. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018[J]. Front Endocrinol(Lausanne), 2022, 13:1071465. doi:10.3389/fendo.2022.1071465
[10] PENG T P, DAI S N, WU D, et al. The U-shaped correlation between serum VD concentration and systemic immune-inflammatory index: Results from the NHANES database prospective cohort study[J]. BMC Public Health, 2024, 24(1):3570-3580. doi:10.1186/s12889-024-21133-0
[11] DZIEDZIC E A, G?SIOR J S, TUZIMEK A, et al. The Association between Serum Vitamin D Concentration and New Inflammatory Biomarkers-Systemic Inflammatory Index(SII) and Systemic Inflammatory Response(SIRI)-In Patients with Ischemic Heart Disease[J]. Nutrients, 2022, 14(19):4212-4224. doi:10.3390/nu14194212
[12] 中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物的临床应用共识[J]. 中华内分泌代谢杂志, 2018,34(3):187-201.
[13] ZHANG P, GUO D, XU B, et al. Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study[J]. Diabetes Care, 2022, 45(5):1219-1229. doi:10.2337/dc21-2193
[14] SACERDOTE A, DAVE P, LOKSHIN V, et al. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D[J]. Curr Diab Rep, 2019, 19(10):101-112. doi:10.1007/s11892-019-1201-y
[15] WAN Z, GUO J, PAN A, et al. Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes[J]. Diabetes Care, 2021, 44(2):350-357. doi:10.2337/dc20-1485
[16] SHAN R, ZHANG Q, DING Y, et al. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights[J]. Open Life Sci, 2024, 19(1):20220787. doi:10.1515/biol-2022-0787
[17] AL G H, ALRAMADAN M S, AL A M, et al. Vitamin D Serum Levels in Type 2 Diabetic Patients: A Cross-Sectional Study[J]. Cureus, 2022, 14(2):e22558.
[18] 金更学, 徐翔宇, 韩江, 等. 2型糖尿病患者血清炎症因子及25羟维生素D水平与血管病变的相关性分析[J]. 中华糖尿病杂志, 2023,15(Z2):23-28.
[19] OKUYAN O, DUMUR S, ELGORMUS N, et al. The Relationship between Vitamin D, Inflammatory Markers, and Insulin Resistance in Children[J]. Nutrients, 2024, 16(17):3005-3016. doi:10.3390/nu16173005
[20] CARLBERG C. Vitamin D Signaling in the Context of Innate Immunity: Focus on Human Monocytes[J]. Front Immunol, 2019, 10:2211. doi:10.3389/fimmu.2019.02211
[21] TAY H M, YEAP W H, DALAN R, et al. Increased monocyte-platelet aggregates and monocyte-endothelial adhesion in healthy individuals with vitamin D deficiency[J]. FASEB J, 2020, 34(8):11133-11142. doi:10.1096/fj.202000822r
[22] BISHOP E L, ISMAILOVA A, DIMELOE S, et al. Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti-Inflammatory[J]. JBMR Plus, 2021, 5(1):e10405. doi:10.1002/jbm4.10405
[23] CHAUSS D, FREIWALD T, MCGREGOR R, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of T(H)1 cells[J]. Nat Immunol, 2022, 23(1):62-74. doi:10.1038/s41590-021-01080-3
[24] S?RBE C, REDNIC S, GRAMA A, et al. An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases[J]. Int J Mol Sci, 2022, 23(17):9784-9812. doi:10.3390/ijms23179784
文章导航

/